诺瓦瓦克斯医药 NVAX 深 沪
等待开盘 12-01 09:30:00 美东时间
7.05
+0.100
+1.44%
华盛通- 最 高7.06
- 今 开6.97
- 成交量 152.38万股
- 最 低 6.90
- 昨 收 6.95
- 总市值 11.42亿
- 52周最高 11.55
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 5.01
- 委 比 -40.80%
- 总股本 1.62亿
- 历史最高 331.68
- 量 比 0.44
- 振 幅 2.30%
- 历史最低 3.5324
- 每 手 1
- 风险率 1.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA official Prasad says COVID shot deaths mean stricter vaccine approval standards
Vinay Prasad, the head of the US FDA's Center for Biologics Evaluations and Research which oversees vaccines, said that future vaccine approvals will face stricter standards in light of the deaths of ...
11-30 00:50
Novamax rises after a seven-day slide
Novavax (NVAX) rose 4.98% to $6.53 in afternoon trading on Friday, snapping a seven-session losing streak, with notable drops of 3.38% and 3.50% on November 18 and 19. Novavax now expects to reach pro...
11-22 02:03
Under the Radar: Why This 600M Fund Manager Keeps Outperforming Wall Street
While everyone else is running in circles over the next week breathlessly talki...
11-18 23:42
Novavax to Participate in Jefferies London Healthcare Conference
GAITHERSBURG, Md., Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthc...
11-12 21:00
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday?
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
11-07 01:45
Novavax Raises FY2025 Sales Guidance from $1.000B-$1.050B to $1.040B-$1.060B vs $1.051B Est
Novavax (NASDAQ:NVAX) raises FY2025 sales outlook from $1.000 billion-$1.050 billion to $1.040 billion-$1.060 billion vs $1.051 billion estimate.
11-06 21:03
Novavax Q3 EPS $(1.25) Beats $(1.33) Estimate, Sales $70.445M Beat $42.133M Estimate
Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.25) per share which beat the analyst consensus estimate of $(1.33) by 6.3 percent. This is a 64.47 percent decrease over losses of $(0.76) per share from the same
11-06 20:54
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
An Overview of Novavax's Earnings
Novavax (NASDAQ:NVAX) is preparing to release its quarterly earnings on Thursda...
11-06 03:03
